Adcytherix
Founded 2022 · 8 known investors
Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology. Its lead candidate, ADCX-020, is being evaluated in a Phase 1 study in patients with advanced solid tumors.
BiotechHealthtechMedical Devices
Founders & leadership
Adcytherix was founded in 2022 by Jack Elands and Xavier Preville.
JE
Jack ElandsFounder & CEO
XP
Xavier PrevilleCo-founder, VP & Head of Research & Preclinical Development
JH
Jan H.M. SchellensChief Medical Officer
TM
Thierry MenguyVP & Head of CMC Operations
JA
Jaime ArangoChief Financial Officer
PJ
Paul JacksonChief Operating Officer
MG
Magali GibouChief Regulatory & Quality Officer
IP
Inka PawlitzkyVP & Head of Clinical Development
JG
Julia GavrilyukVP & Head of ADC Technology Development
Investors · 8
In the news
Frequently asked questions
- What does Adcytherix do?
- Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology. Its lead candidate, ADCX-020, is being evaluated in a Phase 1 study in patients with advanced solid tumors.
- Who founded Adcytherix?
- Adcytherix was founded by Jack Elands, Xavier Preville in 2022.
- Who are Adcytherix's investors?
- Adcytherix's investors include aMoon, RA Capital, Bpifrance, Andera Partners, Angelini Ventures, Kurma Partners, Pontifax Venture Capital, Pureos Bioventures.